JUAN CABRERA: Open Payments
NPI 1295742377 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,429 in 166 payments from 21 companies in 2025. Trend: 2023 $2,470 · 2024 $1,898 · 2025 $2,429
Food & beverage: $2,422Education: $8
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $282 |
| ABBVIE INC. | 29 | $274 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $263 |
| Alkermes, Inc. | 17 | $260 |
| Janssen Pharmaceuticals, Inc | 15 | $203 |
| Collegium Pharmaceutical, Inc. | 13 | $187 |
| Otsuka America Pharmaceutical, Inc. | 13 | $183 |
| Supernus Pharmaceuticals, Inc. | 11 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $91 |
| Grifols USA, LLC | 3 | $88 |
Products named: Auvelity, VRAYLAR, CAPLYTA, ARISTADA, Jornay PM, SPRAVATO, REXULTI, Qelbree.
Industry payments across IN — which companies pay providers there.
